# MSN Laboratories Private Limited, Unit-II - Inspection Records

Source: https://www.keypedia.com/companies/msn-laboratories-private-limited-unit-ii/539d7af5-94e6-4abe-b01b-fa911be84d2a

> Inspection records and compliance data for MSN Laboratories Private Limited, Unit-II in Sangareddy District, NA. Access full analysis and detailed observations.

---

## Details

- Name: MSN Laboratories Private Limited, Unit-II
- FEI Number: 3008656542
- City: Sangareddy District
- State: NA
- Country Name: India
- Address Line 1: Patancheru
- Zip Code: 50230
- Business Operations: API MANUFACTURE

## Related Documents

- [483 - MSN Laboratories Private Limited, Unit-II - 2024-03-22](https://www.keypedia.com/records/483/msn-laboratories-private-limited-unit-ii/2086fcb4-ba6f-4b62-91be-759d5efa8f51) — source: FDA, date: March 22, 2024
- [FDA Inspection 1236036 - MSN Laboratories Private Limited, Unit-II - 2024-03-22](https://www.keypedia.com/records/fda_inspections/msn-laboratories-private-limited-unit-ii/3d84b80d-e48d-4c74-a537-2409078c643e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 22, 2024
- [EIR - MSN Laboratories Private Limited, Unit-II - 2018-05-25](https://www.keypedia.com/records/eir/msn-laboratories-private-limited-unit-ii/d98165d9-f691-4430-80c7-892984206a91) — source: FDA, date: May 25, 2018
- [FDA Inspection 1057811 - MSN Laboratories Private Limited, Unit-II - 2018-05-25](https://www.keypedia.com/records/fda_inspections/msn-laboratories-private-limited-unit-ii/a951698d-23d7-42d7-b227-5428f34ecf0a) — classification: No Action Indicated (NAI), source: FDA, date: May 25, 2018
- [FDA Inspection 922563 - MSN Laboratories Private Limited, Unit-II - 2015-04-03](https://www.keypedia.com/records/fda_inspections/msn-laboratories-private-limited-unit-ii/0a720dad-e274-43c2-a0f7-253195bf84dc) — classification: No Action Indicated (NAI), source: FDA, date: April 3, 2015

## Related Companies

- [Lonza Biologics, Inc.](https://www.keypedia.com/companies/lonza-biologics-inc/f9882ce5-d92a-4c88-916e-8f4e6d1f2aff)
- [Biogen MA Inc.](https://www.keypedia.com/companies/biogen-ma-inc/85b778d2-1e69-485d-9e93-05c656646fa2)
- [GlaxoSmithKline dba Human Genome Sciences Inc](https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc)
- [Solara Active Pharma Sciences Limited](https://www.keypedia.com/companies/solara-active-pharma-sciences-limited/8f3f8236-f49d-43e3-84af-2cb404fb8264)
- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/f0157d2d-6b0c-4b13-afd4-551c2ab94aad)
- [Organo Sintesis, S.A. De C.V.](https://www.keypedia.com/companies/organo-sintesis-sa-de-cv/0d8f4d8d-0fbd-4c4a-8362-439c74e4f37d)
- [UQUIFA Mexico, S.A. de C.V.](https://www.keypedia.com/companies/uquifa-mexico-sa-de-cv/8523a240-e52a-495e-a781-e12c6412dc69)
- [Spark Therapeutics, Inc.](https://www.keypedia.com/companies/spark-therapeutics-inc/a5518493-a117-41d3-862d-96d5a5d3b6dd)
- [AGILENT TECHNOLOGIES INC./US](https://www.keypedia.com/companies/agilent-technologies-incus/f39880d4-233e-44bc-9a9e-56d1f9b48065)
- [Lonza AG](https://www.keypedia.com/companies/lonza-ag/7084f7e6-ce36-429f-942a-28e759416e70)

## Related Officers

- [GDUFA Supervisory Investigator](https://www.keypedia.com/people/paul-c-mouris/0da88ac4-d475-412f-8505-5a43dc8aea41)
- [issuing_officer](https://www.keypedia.com/people/gam-s-zamil/75bc04d4-6013-43b5-8200-8b513c814a7c)
- [M.S., Consumer Safety Officer at FDA](https://www.keypedia.com/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)